These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 11030149

  • 81. Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation.
    Capper D, Gaiser T, Hartmann C, Habel A, Mueller W, Herold-Mende C, von Deimling A, Siegelin MD.
    Acta Neuropathol; 2009 Apr; 117(4):445-56. PubMed ID: 19214542
    [Abstract] [Full Text] [Related]

  • 82.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 83. Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death.
    Ibrahim SM, Ringel J, Schmidt C, Ringel B, Müller P, Koczan D, Thiesen HJ, Löhr M.
    Pancreas; 2001 Jul; 23(1):72-9. PubMed ID: 11451151
    [Abstract] [Full Text] [Related]

  • 84. TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy.
    Lincz LF, Yeh TX, Spencer A.
    Leukemia; 2001 Oct; 15(10):1650-7. PubMed ID: 11587225
    [Abstract] [Full Text] [Related]

  • 85.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 86. TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer.
    Odoux C, Albers A, Amoscato AA, Lotze MT, Wong MK.
    Int J Cancer; 2002 Feb 01; 97(4):458-65. PubMed ID: 11802207
    [Abstract] [Full Text] [Related]

  • 87. Cellular FLICE/caspase-8-inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma.
    Okano H, Shiraki K, Inoue H, Kawakita T, Yamanaka T, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Fujikawa K, Murata K, Nakano T.
    Lab Invest; 2003 Jul 01; 83(7):1033-43. PubMed ID: 12861043
    [Abstract] [Full Text] [Related]

  • 88. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines.
    Jaganathan J, Petit JH, Lazio BE, Singh SK, Chin LS.
    Neurosurg Focus; 2002 Sep 15; 13(3):ecp1. PubMed ID: 15844877
    [Abstract] [Full Text] [Related]

  • 89. Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis.
    Zang DY, Goodwin RG, Loken MR, Bryant E, Deeg HJ.
    Blood; 2001 Nov 15; 98(10):3058-65. PubMed ID: 11698291
    [Abstract] [Full Text] [Related]

  • 90. Caspase-10 sensitizes breast carcinoma cells to TRAIL-induced but not tumor necrosis factor-induced apoptosis in a caspase-3-dependent manner.
    Engels IH, Totzke G, Fischer U, Schulze-Osthoff K, Jänicke RU.
    Mol Cell Biol; 2005 Apr 15; 25(7):2808-18. PubMed ID: 15767684
    [Abstract] [Full Text] [Related]

  • 91. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Burkitt's lymphoma cell lines.
    Mouzakiti A, Packham G.
    Br J Haematol; 2003 Jul 15; 122(1):61-9. PubMed ID: 12823346
    [Abstract] [Full Text] [Related]

  • 92.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 93. mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells.
    Panner A, James CD, Berger MS, Pieper RO.
    Mol Cell Biol; 2005 Oct 15; 25(20):8809-23. PubMed ID: 16199861
    [Abstract] [Full Text] [Related]

  • 94. Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis.
    Higuchi H, Yoon JH, Grambihler A, Werneburg N, Bronk SF, Gores GJ.
    J Biol Chem; 2003 Jan 03; 278(1):454-61. PubMed ID: 12407100
    [Abstract] [Full Text] [Related]

  • 95.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 96. Resistance to TRAIL is associated with defects in ceramide signaling that can be overcome by exogenous C6-ceramide without requiring down-regulation of cellular FLICE inhibitory protein.
    Voelkel-Johnson C, Hannun YA, El-Zawahry A.
    Mol Cancer Ther; 2005 Sep 03; 4(9):1320-7. PubMed ID: 16170023
    [Abstract] [Full Text] [Related]

  • 97.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 98. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas.
    Kim S, Kang J, Qiao J, Thomas RP, Evers BM, Chung DH.
    J Pediatr Surg; 2004 Apr 03; 39(4):516-21. PubMed ID: 15065019
    [Abstract] [Full Text] [Related]

  • 99. Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma.
    Azuhata T, Scott D, Griffith TS, Miller M, Sandler AD.
    J Pediatr Surg; 2006 Aug 03; 41(8):1431-40. PubMed ID: 16863850
    [Abstract] [Full Text] [Related]

  • 100. TRAIL/Apo-2L: mechanisms and clinical applications in cancer.
    Srivastava RK.
    Neoplasia; 2001 Aug 03; 3(6):535-46. PubMed ID: 11774036
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.